Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

It marks J&J’s first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.  

Previous post Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge
Next post Bank of America tops profit estimates on better-than-expected interest income